PRAX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Praxis Precision Medicines Inc (PRAX).


$1.43B Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

PRAX Market Cap. (MRY)


PRAX Shares Outstanding (MRY)


PRAX Assets (MRY)


Total Assets

$483.11M

Total Liabilities

$37.66M

Total Investments

$254.16M

PRAX Income (MRY)


Revenue

$8.55M

Net Income

-$182.82M

Operating Expense

$208.72M

PRAX Cash Flow (MRY)


CF Operations

-$131.76M

CF Investing

-$248.49M

CF Financing

$514.32M

PRAX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PRAX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$483,110,000 (449.31%)

$87,948,000 (-23.61%)

$115,128,000 (-60.67%)

$292,747,000 (-3.44%)

Assets Current

$404,372,000 (376.40%)

$84,880,000 (-23.42%)

$110,840,000 (-61.43%)

$287,409,000 (-4.93%)

Assets Non-Current

$78,738,000 (2466.43%)

$3,068,000 (-28.45%)

$4,288,000 (-19.67%)

$5,338,000 (527.26%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$445,450,000 (539.38%)

$69,669,000 (-8.46%)

$76,106,000 (-69.66%)

$250,812,000 (-12.75%)

Property Plant & Equipment Net

$1,361,000 (-48.68%)

$2,652,000 (-31.51%)

$3,872,000 (-20.43%)

$4,866,000 (482.06%)

Cash & Equivalents

$215,372,000 (164.91%)

$81,300,000 (31.95%)

$61,615,000 (-55.58%)

$138,704,000 (-53.24%)

Accumulated Other Comprehensive Income

$654,000 (0%)

$0 (0%)

-$173,000 (1.70%)

-$176,000 (0%)

Deferred Revenue

$0 (0%)

$2,553,000 (-48.94%)

$5,000,000 (0%)

$0 (0%)

Total Investments

$254,156,000 (0%)

$0 (0%)

$38,874,000 (-71.67%)

$137,207,000 (0%)

Investments Current

$177,195,000 (0%)

$0 (0%)

$38,874,000 (-71.67%)

$137,207,000 (0%)

Investments Non-Current

$76,961,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$12,528,000 (115.44%)

$5,815,000 (-60.37%)

$14,672,000 (36.10%)

$10,780,000 (163.70%)

Accumulated Retained Earnings (Deficit)

-$836,740,000 (-27.96%)

-$653,921,000 (-23.23%)

-$530,644,000 (-67.60%)

-$316,615,000 (-111.71%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,369,000 (-45.13%)

$2,495,000 (-28.71%)

$3,500,000 (-18.81%)

$4,311,000 (465.01%)

Debt Current

$1,259,000 (11.81%)

$1,126,000 (12.04%)

$1,005,000 (24.07%)

$810,000 (6.16%)

Debt Non-Current

$110,000 (-91.96%)

$1,369,000 (-45.13%)

$2,495,000 (-28.73%)

$3,501,000 (0%)

Total Liabilities

$37,660,000 (106.03%)

$18,279,000 (-53.16%)

$39,022,000 (-6.95%)

$41,935,000 (166.76%)

Liabilities Current

$37,550,000 (138.43%)

$15,749,000 (-54.14%)

$34,345,000 (-10.64%)

$38,434,000 (144.49%)

Liabilities Non-Current

$110,000 (-95.65%)

$2,530,000 (-45.91%)

$4,677,000 (33.59%)

$3,501,000 (0%)

PRAX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$8,553,000 (249.53%)

$2,447,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$56,305,000 (33.89%)

$42,054,000 (-29.85%)

$59,946,000 (27.34%)

$47,075,000 (177.04%)

Research & Development Expense

$152,413,000 (75.66%)

$86,766,000 (-44.04%)

$155,040,000 (28.92%)

$120,257,000 (167.38%)

Operating Expenses

$208,718,000 (62.02%)

$128,820,000 (-40.08%)

$214,986,000 (28.48%)

$167,332,000 (170.03%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$182,819,000 (-48.30%)

-$123,277,000 (42.40%)

-$214,029,000 (-28.11%)

-$167,061,000 (-170.24%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$182,819,000 (-48.30%)

-$123,277,000 (42.40%)

-$214,029,000 (-28.11%)

-$167,061,000 (-170.24%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$182,819,000 (-48.30%)

-$123,277,000 (42.40%)

-$214,029,000 (-28.11%)

-$167,061,000 (-137.56%)

Weighted Average Shares

$17,906,794 (171.55%)

$6,594,316 (114.58%)

$3,073,116 (-92.76%)

$42,454,055 (374.34%)

Weighted Average Shares Diluted

$17,906,794 (171.55%)

$6,594,316 (114.58%)

$3,073,116 (-92.76%)

$42,454,055 (374.34%)

Earning Before Interest & Taxes (EBIT)

-$182,819,000 (-48.30%)

-$123,277,000 (42.40%)

-$214,029,000 (-28.11%)

-$167,061,000 (-170.20%)

Gross Profit

$8,553,000 (249.53%)

$2,447,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$200,165,000 (-58.39%)

-$126,373,000 (41.22%)

-$214,986,000 (-28.48%)

-$167,332,000 (-170.03%)

PRAX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$248,494,000 (-737.98%)

$38,950,000 (-59.80%)

$96,889,000 (168.95%)

-$140,520,000 (0%)

Net Cash Flow from Financing

$514,323,000 (459.83%)

$91,871,000 (777.89%)

$10,465,000 (-90.27%)

$107,586,000 (-64.66%)

Net Cash Flow from Operations

-$131,757,000 (-18.55%)

-$111,136,000 (39.94%)

-$185,043,000 (-48.56%)

-$124,554,000 (-136.69%)

Net Cash Flow / Change in Cash & Cash Equivalents

$134,072,000 (581.09%)

$19,685,000 (125.34%)

-$77,689,000 (50.67%)

-$157,488,000 (-162.55%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$248,494,000 (-737.16%)

$39,000,000 (-59.93%)

$97,333,000 (169.79%)

-$139,470,000 (0%)

Capital Expenditure

$0 (0%)

-$50,000 (88.74%)

-$444,000 (57.71%)

-$1,050,000 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$514,631,000 (461.87%)

$91,592,000 (754.00%)

$10,725,000 (-90.03%)

$107,586,000 (-46.47%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$41,360,000 (66.39%)

$24,857,000 (-13.07%)

$28,593,000 (26.00%)

$22,693,000 (335.48%)

Depreciation Amortization & Accretion

$1,291,000 (1.73%)

$1,269,000 (8.37%)

$1,171,000 (-26.54%)

$1,594,000 (113.67%)

PRAX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

-

Profit Margin

-2137.50% (57.57%)

-5037.90%

-

-

EBITDA Margin

-2122.40% (57.43%)

-4986.00%

-

-

Return on Average Equity (ROAE)

-49.50% (67.22%)

-151.00% (9.85%)

-167.50% (-187.31%)

-58.30% (14.39%)

Return on Average Assets (ROAA)

-46.00% (60.21%)

-115.60% (9.26%)

-127.40% (-138.13%)

-53.50% (-33.42%)

Return on Sales (ROS)

-2137.50% (57.57%)

-5037.90%

-

-

Return on Invested Capital (ROIC)

-90.60% (-106.68%)

1357.10% (547.59%)

-303.20% (-153.94%)

-119.40% (-110.49%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7.54 (-532.38%)

-1.19 (-132.36%)

-0.51 (89.74%)

-5 (28.57%)

Price to Sales Ratio (P/S)

161.13 (168.36%)

60.04

-

-

Price to Book Ratio (P/B)

3.22 (17.48%)

2.74 (85.96%)

1.47 (-58.16%)

3.52 (-51.89%)

Debt to Equity Ratio (D/E)

0.09 (-67.56%)

0.26 (-48.93%)

0.51 (207.19%)

0.17 (203.64%)

Earnings Per Share (EPS)

-10.21 (45.37%)

-18.69 (73.15%)

-69.6 (-1666.50%)

-3.94 (49.87%)

Sales Per Share (SPS)

0.48 (28.84%)

0.37 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-7.36 (56.36%)

-16.86 (72.07%)

-60.36 (-1939.81%)

-2.96 (49.68%)

Book Value Per Share (BVPS)

24.88 (135.46%)

10.56 (-57.34%)

24.77 (319.18%)

5.91 (-81.61%)

Tangible Assets Book Value Per Share (TABVPS)

26.98 (102.29%)

13.34 (-64.40%)

37.46 (443.26%)

6.9 (-79.64%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (-600.00%)

-1 (0%)

0 (0%)

-4 (87.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

-6.98 (-819.89%)

-0.76 (-202.39%)

-0.25 (94.25%)

-4.37 (86.60%)

Asset Turnover

0.02 (-4.35%)

0.02 (0%)

0 (0%)

0 (0%)

Current Ratio

10.77 (99.80%)

5.39 (67.03%)

3.23 (-56.85%)

7.48 (-61.12%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$131,757,000 (-18.50%)

-$111,186,000 (40.06%)

-$185,487,000 (-47.68%)

-$125,604,000 (-138.69%)

Enterprise Value (EV)

$1,267,378,318 (1268.50%)

$92,610,826 (73.31%)

$53,435,216 (-92.60%)

$722,392,807 (-63.71%)

Earnings Before Tax (EBT)

-$182,819,000 (-48.30%)

-$123,277,000 (42.40%)

-$214,029,000 (-28.11%)

-$167,061,000 (-170.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$181,528,000 (-48.78%)

-$122,008,000 (42.68%)

-$212,858,000 (-28.64%)

-$165,467,000 (-170.89%)

Invested Capital

$231,557,000 (3605.25%)

-$6,606,000 (-129.14%)

$22,668,000 (-81.10%)

$119,920,000 (1529.66%)

Working Capital

$366,822,000 (430.62%)

$69,131,000 (-9.63%)

$76,495,000 (-69.28%)

$248,975,000 (-13.13%)

Tangible Asset Value

$483,110,000 (449.31%)

$87,948,000 (-23.61%)

$115,128,000 (-60.67%)

$292,747,000 (-3.44%)

Market Capitalization

$1,434,363,318 (651.21%)

$190,939,826 (70.27%)

$112,142,216 (-87.31%)

$883,658,807 (-58.02%)

Average Equity

$369,224,750 (352.32%)

$81,629,500 (-36.12%)

$127,790,000 (-55.40%)

$286,505,250 (177.56%)

Average Assets

$397,709,500 (272.95%)

$106,638,500 (-36.52%)

$167,987,750 (-46.24%)

$312,479,750 (78.12%)

Invested Capital Average

$201,768,000 (2321.14%)

-$9,084,000 (-112.87%)

$70,597,500 (-49.54%)

$139,903,250 (2674.59%)

Shares

18,637,777 (117.48%)

8,570,010 (172.82%)

3,141,239 (-93.00%)

44,855,777 (17.23%)